Özlem IZCI İzci Ay

Prof. Dr. Özlem IZCI İzci Ay

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2015 in Indian Journal of Hematology and Blood Transfusion
Verified
Journal Article
Open access
PDF file
ATANIL TOMBAK
ANIL TOMBAK
ÖAÖzlem IZCI İzci Ay
Özlem IZCI İzci Ay
Mehmet Emin ErdalMehmet Emin Erdal
Mehmet Emin Erdal
MSMehmet Ali SUNGUR
Mehmet Ali SUNGUR
MUMehmet Ali Uçar
Mehmet Ali Uçar
ETEyup Naci Tiftik
Eyup Naci Tiftik
MicroRNAs (miRNA) are small non-coding RNA molecules that play critical roles in cell differentiation, proliferation and apoptosis and thus regulate haematopoietic stem cells and committed progenitor cells. We analyzed expressions of miRNAs associated with hematopoietic transformation of myeloid, erythroid and megakaryocytic progenitor cells during haematopoiesis (mir155, mir181a, mir221, mir222, mir223, mir451), in patients with primary myelofibrosis (PMF) (n = 22), polycythemia vera (PV) (n = 33), essential thrombocythemia (ET) (n = 49) and in healthy controls (n = 40) by quantitate/real time polymerase chain reaction. RT-PCR testing was negative for BCR–ABL1 fusion gene in all the patients. Mir155 was expressed in higher levels in all 3 disorders (p 0.05). Mir451 levels were lower in all three groups compared to control group (p JAK2V617F positivity, co-morbidities, drugs, and gender did not affect miRNA expressions. This study holds promise for the future application of these molecules for differential diagnosis and as therapeutic targets in Philadelphia chromosome negative myeloproliferative neoplasms.

29 April 2010 in Journal of Biomedicine and Biotechnology
Verified
Journal Article
Open access
PDF file
MBMahmut Balkan
Mahmut Balkan
AGAbdullah Gedik
Abdullah Gedik
HAHasan Akkoc
Hasan Akkoc
ÖAÖzlem IZCI İzci Ay
Özlem IZCI İzci Ay
Mehmet Emin ErdalMehmet Emin Erdal
Mehmet Emin Erdal
TBTurgay Budak
Turgay Budak
The influence of FSH receptor (FSHR) variants on male infertility is not completely understood. The present investigation is the first screening study for SNP at nucleotide position −29 in the core promoter region and codon 680 in exon 10 of theFSHRand the effect of the serum levels of FSH on male infertility in Southeast Turkey. The SNPs in codon 680 and at position −29 of theFSHRgene were analyzed by PCR-RFLP technique in 240 men with proven fathers, and 270 infertile men (150 nonobstructive azoospermic and 120 severe oligozoospermic). The separate analysis for SNP at nucleotide position −29 did not show any difference in genotypic frequencies and serum FSH levels. The genotype distribution of SNP at position 680 was different but does not influence serum FSH levels. Together the two SNPs form four discrete haplotypes (A-Thr-Asn, G-Thr-Asn, A-Ala-Ser, and G-Ala-Ser) occurring in 10 combinations. A statistically significant difference in the allelic distribution of G-Asn/G-Ser and G-Ser/G-Ser genotype between proven fathers and infertile men but there were not any statistically significant difference in the overall frequency of the four FSHR haplotypes. We conclude that the FSHR haplotype does not associate with different serum FSH levels but it is differently distributed in proven fathers and infertile men.

24 June 2022 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
STSevinç Sürer Tekin
Sevinç Sürer Tekin
Mehmet Emin ErdalMehmet Emin Erdal
Mehmet Emin Erdal
MAMehmet Asoğlu
Mehmet Asoğlu
ÖAÖzlem IZCI İzci Ay
Özlem IZCI İzci Ay
MAMustafa Ertan Ay
Mustafa Ertan Ay
ŞYŞenay Görücü Yılmaz
Şenay Görücü Yılmaz
Objective: Bipolar I disorder (BD-I) is a type of bipolar spectrum disorder characterized by manic or mixed episodes. Detecting microRNA regulations as epigenetic actors in BD-I is important to elucidate the pathogenesis of the disease and reveal the potential of microRNAs (miRNAs) as biomarkers.Methods: We evaluated the expression profile of six candidate miRNAs (hsa-miR-145-5p, hsa-miR376a-3p, hsa-miR-3680-5p, hsa-miR-4253-5p, hsa-miR-4482-3p, and hsa-miR-4725) in patients with BD-I and in healthy controls (aged 11-50 years). We also determined the potential target genes of these miRNAs through in silico analysis. The diagnostic values of the miRNAs were calculated through receiver operating characteristic curve analysis.Results: Four miRNAs were upregulated (hsa-miR-376a-3p, hsa-miR-3680-5p, hsa-miR-4253-5p, hsa-miR-4482-3p) and hsa-miR-145-5p was downregulated in patients (p o 0.001). The target gene analyses showed that hsa-miR-145-5p specifically targets the dopamine decarboxylase (DDC) gene. The area under the curve of hsa-miR-145-5p was 0.987.Conclusion: Differential expression of five miRNAs in peripheral blood may be associated with the pathogenesis of BD-I, and hsa-miR-145-5p has potential as a BD-I biomarker. This miRNA can be used in dopamine-serotonin regulation and dose adjustment in drug therapy via the DDC gene.

19 December 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
CACemile Ardıç
Cemile Ardıç
MAMustafa Ertan Ay
Mustafa Ertan Ay
KÇKenan Çevik
Kenan Çevik
ATANIL TOMBAK
ANIL TOMBAK
ÖAÖzlem IZCI İzci Ay
Özlem IZCI İzci Ay
Mehmet Emin ErdalMehmet Emin Erdal
Mehmet Emin Erdal
Background: Myelodysplastic syndromes (MDSs) and acute myeloid leukemia (AML) are clonal hematological disorders that share molecular origins but present with distinct clinical features. MicroRNAs (miRNAs) are key post-transcriptional regulators, and their altered expression may reflect biological shifts contributing to disease progression. Methods: Expression levels of miR-155, miR-181, miR-221, miR-222, and miR-223 were analyzed by RT-qPCR in bone marrow samples from 37 MDS patients, 20 AML patients, and 7 controls. Group comparisons were performed using ANOVA (with Benjamini–Hochberg correction) and Tukey post hoc testing. Diagnostic performance and network behavior were evaluated using ROC analysis, Pearson correlation matrices, and principal component analysis (PCA). Results: miR-155, miR-181, and miR-223 were upregulated in AML, whereas miR-221 and miR-222 were downregulated. miR-222 showed the highest diagnostic accuracy (AUC ~0.87 for both AML vs. control and MDS vs. control). Its expression was significantly higher in high IPSS-R MDS cases (p = 0.046), with a similar upward tendency for miR-221 (p = 0.054). Progressive loss of coordinated miRNA expression was observed from controls to MDS and AML. PCA supported these findings by showing separation mainly driven by miR-222 and miR-155. Conclusions: Combined miRNA profiling highlights miR-222 and, to a lesser extent miR-155, as consistent indicators of myeloid disease transformation. While further validation in larger and genetically stratified cohorts is warranted, these findings support the potential contribution of miRNA signatures to diagnostic evaluation and risk stratification in MDS and AML, in line with precision hematology approaches.

1 March 2016 in Klinik Psikofarmakoloji Bülteni / Bulletin of Clinical Psychopharmacology
Verified
Journal Article
Open access
CSCem Sengul
Cem Sengul
Mehmet Emin ErdalMehmet Emin Erdal
Mehmet Emin Erdal
CSCeyhan Balci Sengul
Ceyhan Balci Sengul
ÖAÖzlem IZCI İzci Ay
Özlem IZCI İzci Ay
ABAhmet Büber
Ahmet Büber
HHHasan Herken
Hasan Herken
Objective: Alcoholism is associated with genetic variants of genes related to alcohol metabolizing enzymes, dopaminergic, gamma-aminobutyric acidergic, glutamatergic, opioid, cholinergic, and serotonergic systems. Neurpeptide Y system and Neurexins were shown to be associated with alcohol dependence. Recent studies identified new genetic polymorphisms related to endogenous cannabinoid system, neuropetide Y and neurexin. In the present study, we aimed to investigate the association of Neurpeptide Y LEU7PRO rs16139 and neurexin 3 gene rs760288 polymorphisms with alcohol dependence in patients with alcohol dependence and healthy control subjects. Methods: 123 patients who were diagnosed with alcohol dependence according to the DSM-IV criteria and 159 healthy volunteers were included in the study. Blood samples were used to investigate polymorphisms. The genotyping of the neurexin 3 gene rs760288 and the neuropetide Y gene Leu7Pro rs16139 polymorphisms was performed using TaqMan SNP Genotyping Assays Real-Time PCR System. Results: Of the 2 genetic polymorphisms investigated in the present study, we detected association between and neurexin 3 gene rs760288 polymorphisms with alcohol dependence. Conclusions: Neurexin gene polymorphisms might be an important factor in development of alcohol addiction.

30 March 2015
Verified
Journal Article
Closed access
ASAysu Sen
Aysu Sen
MAMehtap Arslan
Mehtap Arslan
Mehmet Emin ErdalMehmet Emin Erdal
Mehmet Emin Erdal
ÖAÖzlem IZCI İzci Ay
Özlem IZCI İzci Ay
SYSenay Gorucu Yilmaz
Senay Gorucu Yilmaz
BABaki Arpaci
Baki Arpaci